DICHLORPHENAMIDE TABLETS

The FDA-approved generic medication to treat primary hyperkalemic periodic paralysis, primary hypokalemic periodic paralysis, and related variants.

HOW TO SAVE ON TORRENT PHARMA’S DICHLORPHENAMIDE TABLETS

This offer only applies to the following NDC Code:

13668-0676-01 Dichlorphenamide Tablets 50MG 100CT

Dichlorphenamide Copay Savings Card

If you have commercial insurance, pay as little as $0 per prescription

Benefits/Cost of the Savings Program

Eligible patients will pay as little as $0, up to a maximum copay assistance of $10,000 per calendar year. If the drug is not covered, eligible patients may receive one (1) month free product one use per lifetime

Eligibility

Copay program offer not valid for patients enrolled in Medicare, Medicaid, or other federal or state healthcare programs. Please see complete Program Terms, Conditions and Eligibility Criteria

INDICATION

Dichlorphenamide tablets are an oral carbonic anhydrase inhibitor indicated for the treatment of primary hyperkalemic periodic paralysis, primary hypokalemic periodic paralysis, and related variants

IMPORTANT SAFETY INFORMATION

Contraindications

  • Hepatic insufficiency

  • Severe pulmonary obstruction

  • Hypersensitivity to dichlorphenamide or other sulfonamides

  • Concomitant use with high dose aspirin

Warnings and Precautions

  • Hypersensitivity and Other Life-Threatening Reactions: discontinue dichlorphenamide at the first appearance of skin rash or any sign of immune-mediated or idiosyncratic adverse reaction

  • Hypokalemia: baseline and periodic measurements of serum potassium are recommended; if hypokalemia develops or persists, consider reducing the dose or discontinuing dichlorphenamide and correcting potassium levels

  • Metabolic acidosis: baseline and periodic measurements of serum bicarbonate are recommended; if metabolic acidosis develops or persists, consider reducing the dose or discontinuing dichlorphenamide

  • Falls: consider reducing the dose or discontinuing dichlorphenamide in patients who experience falls

Adverse Reactions

  • Most common adverse reactions (incidence at least 10% and greater than placebo) include paresthesias, cognitive disorder, dysgeusia, and confusional state

Drug Interactions

  • Aspirin: anorexia, tachypnea, lethargy and coma have been reported with concomitant use of dichlorphenamide and high-dose aspirin. The concomitant use of dichlorphenamide and high-dose aspirin is contraindicated. Dichlorphenamide should be used with caution in patients receiving lower doses of aspirin.

Use in Specific Populations

  • Pregnancy: Based on animal data, may cause fetal harm

To report SUSPECTED ADVERSE REACTIONS, contact Torrent Pharma, Inc. at 1-800-912-9561 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

Please see Full Prescribing Information